Ventas, Inc. (NYSE:VTR – Get Free Report) announced a quarterly dividend on Monday, September 14th. Stockholders of record on Wednesday, September 30th will be given a dividend of 0.52 per share by the real estate investment trust on Thursday, October 15th. This represents a c) annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Wednesday, September 30th.
Ventas has decreased its dividend by an average of 0.0%annually over the last three years and has increased its dividend every year for the last 1 years. Ventas has a payout ratio of 270.1% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect Ventas to earn $4.29 per share next year, which means the company should continue to be able to cover its $2.08 annual dividend with an expected future payout ratio of 48.5%.
Ventas Stock Performance
Shares of VTR opened at $89.12 on Tuesday. The firm has a market capitalization of $45.71 billion, a P/E ratio of 165.03, a P/E/G ratio of 3.51 and a beta of 0.70. The stock has a 50 day moving average price of $92.83 and a two-hundred day moving average price of $88.00. Ventas has a 52 week low of $66.54 and a 52 week high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.
About Ventas
Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.
The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.
Ventas serves major healthcare and life science markets in the United States and Canada.
Further Reading
- Five stocks we like better than Ventas
- 3 Defense Stocks Riding the High-Energy Laser Boom
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
